Your browser doesn't support javascript.
loading
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV.
Sundell, Jesper; Bienvenu, Emile; Äbelö, Angela; Ashton, Michael.
Afiliación
  • Sundell J; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Bienvenu E; Department of Pharmacy, School of Medicine and Pharmacy, University of Rwanda, Rwanda.
  • Äbelö A; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Ashton M; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
J Antimicrob Chemother ; 76(11): 2950-2957, 2021 10 11.
Article en En | MEDLINE | ID: mdl-34337654
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Fármacos Anti-VIH / Coinfección Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Fármacos Anti-VIH / Coinfección Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Suecia